Tenderwize
Back to tender search

Open-house biologics rebate agreement for Teriparatide

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 29, 2028 · 620 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-06 - Teriparatid

61/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

61 / 100

Complexity

56 / 100

Risk factors

The structured data gives a deadline of 2028-04-29 21:59:59 UTC, while the XML text also mentions 2028-04-30 as an end...

The notice says offers/contracts cannot be submitted via the portal; submission must be by email with qualified electro...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Conclusion of rebate agreements for the active substance Teriparatid.
  • Supply arrangement for pharmaceutical products under an open-house model.
Show full summary

Open-house supply arrangement for pharmaceutical products (Teriparatid) led by Techniker Krankenkasse with HEK and hkk as participating buyers. The procedure is non-exclusive, with no individual negotiations and uniform conditions for all suitable pharmaceutical undertakings. The contract term is up to 24 months from 01.05.2026 and ends no later than 30.04.2028. Documents are available online, but only the XML/tender text was provided here, so procurement documents were not fully analyzed.

Risks

The structured data gives a deadline of 2028-04-29 21:59:59 UTC, while the XML text also mentions 2028-04-30 as an end...

The notice says offers/contracts cannot be submitted via the portal; submission must be by email with qualified electro...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The bidder must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the offered medicinal products.
  • The bidder must have its seat in the AMG territory, another EU Member State, or an EEA state.
  • A valid marketing authorization for the contract medicinal product(s) is required, or another legal basis to place the product on the market in its own name.

Award Criteria

Lot 1

No explicit award criteria provided; open-house uniform conditions only.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-house biologics rebate agreement for Teriparatide

Supply contract for Teriparatid under an open-house procedure. Scope is nationwide in Germany. The arrangement is non-exclusive and open to all eligible pharmaceutical undertakings during the contract period.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Award Criteria

No explicit award criteria provided; open-house uniform conditions only.

Deadline

Deadline Apr 29, 2028

Procurement Details

Publication date
15 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
179543-2026

Documents (1)

Similar tenders